<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01801098</url>
  </required_header>
  <id_info>
    <org_study_id>HV-interval prior TAVI</org_study_id>
    <nct_id>NCT01801098</nct_id>
  </id_info>
  <brief_title>Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI</brief_title>
  <official_title>Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation With a Self-expanding Bioprosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik für Kardiologie, Pneumologie und Angiologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The development of a high grade AV-block is a frequent complication associated with
      transcatheter aortic valve implantation (TAVI). Patients who were suitable for TAVI will be
      enrolled in this study. The HV-interval will be determined before and immediately after
      implantation.

      The hypothesis is that a prolonged HV-interval is associated with a high rate of complete
      AV-block following TAVI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of HV interval</measure>
    <time_frame>Changes in Baseline to 24 hours</time_frame>
    <description>HV-interval will be determined by a 5F quadripolar electrode catheter with a CRD-2 curve configuration. Intracardiac signals will be assessed and determined before and after implantation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AV-block development after 1 month, 6 months and 12 months</measure>
    <time_frame>1 month, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>cardiovascular mortality</measure>
    <time_frame>1 month, 6 months and 12 months</time_frame>
  </other_outcome>
  <enrollment type="Actual">25</enrollment>
  <condition>Symptomatic Aortic Valve Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with symptomatic aortic valve stenosis screened for TAVI will be enrolled in this
        study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic aortic valve stenosis

          -  patients screened for TAVI

          -  written informed consent

        Exclusion Criteria:

          -  unconsciousness, not able to consent

          -  &lt; 18 years

          -  permanent pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malte Kelm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc W. Merx, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonary Diseases, Vascular Medicine University Hospital Duesseldorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong-In Shin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <state>NRW</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uniklinik-duesseldorf.de/Kardiologie</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2013</study_first_submitted>
  <study_first_submitted_qc>February 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2013</study_first_posted>
  <last_update_submitted>November 12, 2013</last_update_submitted>
  <last_update_submitted_qc>November 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Director Division of Cardiology, Pulmonary Diseases, Vascular Medicine</investigator_title>
  </responsible_party>
  <keyword>TAVI</keyword>
  <keyword>complete AV-block</keyword>
  <keyword>HV-interval</keyword>
  <keyword>permanent pacemaker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

